Cite
[Association of monoclonal gammopathy with chronic glomerulonephritis and autoimmune hyperlipemia. Course of disease during therapy].
MLA
Sobel, A. T., et al. “[Association of Monoclonal Gammopathy with Chronic Glomerulonephritis and Autoimmune Hyperlipemia. Course of Disease during Therapy].” La Nouvelle Presse Medicale, vol. 5, no. 36, Oct. 1976, pp. 2375–78. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1068625&authtype=sso&custid=ns315887.
APA
Sobel, A. T., Antonucci, M., Intrator, L., Bernard, D., Beaumont, J. L., & Lagrue, G. (1976). [Association of monoclonal gammopathy with chronic glomerulonephritis and autoimmune hyperlipemia. Course of disease during therapy]. La Nouvelle Presse Medicale, 5(36), 2375–2378.
Chicago
Sobel, A T, M Antonucci, L Intrator, D Bernard, J L Beaumont, and G Lagrue. 1976. “[Association of Monoclonal Gammopathy with Chronic Glomerulonephritis and Autoimmune Hyperlipemia. Course of Disease during Therapy].” La Nouvelle Presse Medicale 5 (36): 2375–78. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1068625&authtype=sso&custid=ns315887.